CRDF
Cardiff Oncology Inc
1.10$
+2.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.6% | +31.4% | -20.5% | +1.2% | -8.5% | -27.8% | +11.0% | -0.8% | +102.5% | -83.1% | +153.7% | – | |
| – | -3.7% | -1.0% | +2.9% | +9,081.0% | -99.0% | – | – | – | – | -0.9% | – | – | |
| – | +55.9% | +94.3% | -43.7% | -16,436.2% | – | -27.8% | -10,612.8% | – | +102.5% | -83.1% | +153.7% | – | |
| – | -3.2% | +3.2% | +18.5% | +1.5% | +0.7% | +7.9% | +10.5% | -29.2% | -38.1% | +33.3% | -12.6% | – | |
| – | +84.7% | -29.5% | -11.9% | +13.4% | -3.7% | +33.3% | -17.3% | +17.5% | -23.1% | +104.5% | -37.9% | – | |
| – | -4.3% | +6.3% | +14.2% | -75.2% | +307.0% | +13.9% | -77.1% | +264.5% | -33.3% | +59.7% | -24.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -98.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.